164 related articles for article (PubMed ID: 15450516)
21. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Ma J; Chen LH; Xia YF; Shi YS
Radiother Oncol; 2005 May; 75(2):197-203. PubMed ID: 15876464
[TBL] [Abstract][Full Text] [Related]
23. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
24. [The study of clinical long-term effect and prognostic factors in nasopharyngeal carcinoma after intensity modulated radiation therapy].
Liu K; Han Y; Ma B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(21):1177-83. PubMed ID: 24616996
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
26. [Long-term efficacy of radiotherapy on children with nasopharyngeal carcinoma].
Cao KJ; Li Y; Huang PY; Xie GF; Huang TB; Hong MH
Ai Zheng; 2004 Nov; 23(11):1322-4. PubMed ID: 15522182
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma.
Cheng SH; Tsai SY; Yen KL; Jian JJ; Feng AC; Chan KY; Hong CF; Chu NM; Lin YC; Lin CY; Tan TD; Hsieh CY; Chong V; Huang AT
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):456-65. PubMed ID: 15667967
[TBL] [Abstract][Full Text] [Related]
28. [Application of magnetic resonance imaging to clinical classification of nasopharyngeal carcinoma].
Cao KJ; Xie CM; Huang PY; Hu D; Sun R; Chen QY
Ai Zheng; 2007 Feb; 26(2):164-7. PubMed ID: 17298746
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma.
Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC
Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.
Foote RL; Weidner N; Harris J; Hammond E; Lewis JE; Vuong T; Ang KK; Fu KK
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):745-53. PubMed ID: 15708253
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of primary tongue carcinoma with second primary tongue carcinoma after radiotherapy for nasopharynx cancer].
Sun CZ; Chen FJ; Zeng ZY; Li QL; Chen YF; Song M
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):938-41. PubMed ID: 17533748
[TBL] [Abstract][Full Text] [Related]
33. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
34. [Radiotherapy on neck for nasopharyngeal carcinoma patients with negative cervical lymph node].
Li Y; Cao KJ; Chen QY; Xie GF; Huang PY
Ai Zheng; 2005 May; 24(5):627-30. PubMed ID: 15890111
[TBL] [Abstract][Full Text] [Related]
35. Staging of nasopharyngeal carcinoma investigated by magnetic resonance imaging.
Lu JC; Wei BQ; Chen WZ; Qian PD; Zhang YQ; Wei Q; Cha WW; Li F; Ni M
Radiother Oncol; 2006 Apr; 79(1):21-6. PubMed ID: 16626827
[TBL] [Abstract][Full Text] [Related]
36. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
37. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
Sha D; He YJ
Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
[TBL] [Abstract][Full Text] [Related]
38. Prevertebral muscle involvement in nasopharyngeal carcinoma.
Feng AC; Wu MC; Tsai SY; Chan KY; Cheng SH; Wang A; Chen SS; Jian JJ; Terng SD; Huang AT
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1026-35. PubMed ID: 16682150
[TBL] [Abstract][Full Text] [Related]
39. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma.
Huang XM; Zheng YQ; Zhang XM; Mai HQ; Zeng L; Liu X; Liu W; Zou H; Xu G
Laryngoscope; 2006 Sep; 116(9):1626-31. PubMed ID: 16954993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
